Clinical Trials

Early thromboprophylaxis in COVID-19 (ETHIC trial): an open label, randomized phase IIIb trial of community-based prophylactic lowmolecular- weight heparin (LMWH) versus standard of care (no enoxaparin) in COVID-19 positive patients

Ficha Técnica

Investigador Principal

JESÚS GONZÁLEZ LAMA

Promotor

THROMBOSIS RESEARCH INSTITUTE

ESTADO

ACTIVO

DEPARTAMENTO

CS Cabra ''Matrona Antonia Mesa Fernández''

Código EudraCT: 2020-003125-39

Número protocolo: TRI-08892

Fecha Inicio: 2021-03-12

Fecha Fin: 2021-07-31